@OpenMedFi
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
OMF is fundraising to support open, collaborative research to find effective treatments and diagnostic markers for ME/CFS, Long COVID, and related diseases.
California, USA
Joined December 2012
- Tweets9.7K
- Following1K
- Followers14.5K
- Likes6.7K
Nearly 1,700 of you completed our deep dive survey on post-exertional symptom worsening.
In the survey we presented two frameworks: a staged model of post-exertional worsening, and a proposed set of outcome measures for decentralized treatment trials.
These survey results go directly into CTN Lite trial design, and we continue to learn from patterns in your responses. They shape the outcome measures we select, the way we define and track PEM, and how we build trial protocols that can accommodate patients
across the full severity spectrum. Want to go deeper into the results? Join Dr. Danielle Meadows for a webinar on October 7 at 3 PM ET.
🔗 Learn more: omf.ngo/pem-deep-dive-survey…
A DSMB is an independent group of medical and scientific experts who watch over a clinical trial while it's happening. They regularly review incoming data to make sure participants aren't being harmed and that the study is running fairly and ethically.
In ME/CFS clinical trials, a DSMB can be a critical safeguard for participants’ wellbeing, particularly in studies that are investigating drugs that haven’t been used frequently or at all in the disease. It can also add a layer of scientific credibility to trials.
OMF’s lite version of a clinical trial network (CTN Lite) will incorporate a DSMB for appropriate trials that are conducted as part of the initiative.
🔗 Read more about CTN Lite on our website: omf.ngo/introducing-ctn-lite…
Last day to complete the Understanding Post-Exertional Symptom Worsening in ME/CFS survey.
Your responses go directly into CTN Lite trial design — shaping the terminology, outcome measures, and how crashes are defined and measured.
👉 Take the Survey: ow.ly/pImY50ZITNr
Open Medicine Foundation retweeted
1/ 🚨Take action by Friday!
NIAID has proposed eliminating its Division of Clinical Research — the infrastructure behind its clinical trials — on a public comment window of just five days. #MECFS #LongCOVID
➡️ Subscribe to OMF's newsletter: ow.ly/mBK850ZOLFY
When you do, you’ll get the latest on OMF research, announcements & more—delivered straight to your inbox. Your information is kept private, and you can unsubscribe anytime.
#pwME #MECFS #LongCOVID #pwLC
Gut dysbiosis is an imbalance in the microorganisms—bacteria, fungi, and viruses—that live in your digestive system. When this “community” is disrupted, it can interfere with digestion, immune function, and even how your brain and body communicate.
cognitive difficulties, and immune dysfunction that people with #MECFS experience.
OMF’s Melbourne ME/CFS Collaboration has explored the relationship between ME/CFS and gut dysbiosis by studying the impact that a common comorbidity, irritable bowel syndrome, has on metabolite signatures of the disease.
🔗 Read more about the project: ow.ly/58j350ZO1TM.
Dr. Janet Mullington and her team released a paper on their investigation of sleep electroencephalographic microstructures. The team studied these microstructures in the context of non-restorative sleep and daytime fatigue in #MECFS and #LongCOVID.
ow.ly/qCkq50ZNXmW
🛍️ With iGive, you can shop online at 1,400+ stores, and a percentage of your purchase will go directly to OMF, at no extra cost to you.
Fuel #MECFS and #LongCOVID research 👉 ow.ly/Lwyc50ZLyYl.
From Dr. Ronald W. Davis: "I'm excited to announce our lineup of speakers for our upcoming Community Symposium on September 11! It will be recorded for those who cannot attend."
Register here: ow.ly/GCHh50ZLXj7
Traditional clinical studies require participants to travel to a single site (a barrier that leaves many people unable to take part). Decentralized studies offer more flexible options for participating in research like local lab visits, home collection kits, or virtual check-ins.
For people living with ME/CFS, where even a short trip can trigger extended periods of worsening symptoms, this flexibility makes meaningful participation in research possible for people who are housebound.
OMF’s Clinical Trials Network Lite (CTN Lite) initiative will include treatment trials that use decentralized study designs, making the studies more accessible to people with more severe ME/CFS.
🔗Read more about CTN Lite: omf.ngo/introducing-ctn-lite…